Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.
Transplantation. 2019 Oct;103(10):2157-2163. doi: 10.1097/TP.0000000000002631.
Despite providing survival benefit, increased risk for infectious disease (IRD) kidney offers are declined at 1.5 times the rate of non-IRD kidneys. Elucidating sources of variation in IRD kidney offer acceptance may highlight opportunities to expand use of these life-saving organs.
To explore center-level variation in offer acceptance, we studied 6765 transplanted IRD kidneys offered to 187 transplant centers between 2009 and 2017 using Scientific Registry of Transplant Recipients data. We used multilevel logistic regression to determine characteristics associated with offer acceptance and to calculate the median odds ratio (MOR) of acceptance (higher MOR indicates greater heterogeneity).
Higher quality kidneys (per 10 units kidney donor profile index; adjusted odds ratio [aOR], 0.94; 95% confidence interval [CI], 0.92-0.95), higher yearly volume (per 10 deceased donor kidney transplants; aOR, 1.08, 95% CI, 1.06-1.10), smaller waitlist size (per 100 candidates; aOR, 0.97; 95% CI, 0.95-0.98), and fewer transplant centers in the donor service area (per center; aOR, 0.88; 95% CI, 0.85-0.91) were associated with greater odds of IRD acceptance. Adjusting for donor and center characteristics, we found wide heterogeneity in IRD offer acceptance (MOR, 1.96). In other words, if listed at a center with more aggressive acceptance practices, a candidate could be 2 times more likely to have an IRD kidney offer accepted.
Wide national variation in IRD kidney offer acceptance limits access to life-saving kidneys for many transplant candidates.
尽管增加了传染病(IRD)肾脏的存活率,但接受 IRD 肾脏的风险是接受非 IRD 肾脏的 1.5 倍。阐明接受 IRD 肾脏的风险差异的来源可能突出了扩大使用这些救命器官的机会。
为了探索中心层面接受 IRD 肾脏的变化,我们使用 Scientific Registry of Transplant Recipients 数据研究了 2009 年至 2017 年间向 187 个移植中心提供的 6765 个移植 IRD 肾脏。我们使用多水平逻辑回归来确定与接受有关的特征,并计算接受的中位数优势比(MOR)(更高的 MOR 表示更大的异质性)。
更高质量的肾脏(每 10 个肾脏捐赠者概况指数单位;调整后的优势比[aOR],0.94;95%置信区间[CI],0.92-0.95)、更高的年度容量(每 10 个已故捐赠者肾脏移植;aOR,1.08,95%CI,1.06-1.10)、较小的等待名单规模(每 100 名候选人;aOR,0.97;95%CI,0.95-0.98)和捐赠服务区域内的移植中心较少(每中心;aOR,0.88;95%CI,0.85-0.91)与接受 IRD 的几率增加有关。在调整了供体和中心特征后,我们发现 IRD 接受率存在广泛的异质性(MOR,1.96)。换句话说,如果在接受更积极的接受实践的中心列出,候选人接受 IRD 肾脏的可能性增加两倍。
IRD 肾脏接受率的全国范围广泛差异限制了许多移植候选人获得救命肾脏的机会。